Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
-
New hope for head and neck cancer patients who Can't take standard chemo
Disease control Not yet recruitingThis study tests two different treatments for people with advanced head and neck cancer who cannot receive the standard drug cisplatin. Participants will get radiation therapy along with either cetuximab (a targeted antibody) or a combination of two chemotherapy drugs, carboplati…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 07:54 UTC
-
New radiation rhythm may boost brain cancer survival and save memory
Disease control Not yet recruitingThis study tests a new way of giving radiation (TMPRT) for a fast-growing brain cancer called glioblastoma that hasn't responded well to standard chemo. About 398 adults with a specific tumor type (MGMT-unmethylated) will get either standard radiation or TMPRT, both with the chem…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Major trial tests skipping radiation for Low-Risk breast cancer
Disease control Not yet recruitingThis study looks at whether women with a low-risk type of early breast cancer (DCIS) can avoid radiation therapy after lumpectomy without a meaningful increase in cancer coming back. About 5,270 women will be grouped by a special test that predicts their risk. Those with low-risk…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 22, 2026 13:50 UTC